Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane with or without Celecoxib in Advanced Breast Cancer
NCT00038103Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2002
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of celecoxib oral solution in breast cancer, sponsored by Pfizer. Started Jan 2002; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00038103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038103.